nodes	percent_of_prediction	percent_of_DWPC	metapath
Sumatriptan—MAOA—attention deficit hyperactivity disorder	0.307	0.385	CbGaD
Sumatriptan—HTR1B—attention deficit hyperactivity disorder	0.293	0.368	CbGaD
Sumatriptan—DRD2—attention deficit hyperactivity disorder	0.197	0.247	CbGaD
Sumatriptan—MAOA—locus ceruleus—attention deficit hyperactivity disorder	0.0081	0.156	CbGeAlD
Sumatriptan—HTR1F—forebrain—attention deficit hyperactivity disorder	0.00332	0.0638	CbGeAlD
Sumatriptan—HTR1F—nervous system—attention deficit hyperactivity disorder	0.0018	0.0346	CbGeAlD
Sumatriptan—HTR1F—central nervous system—attention deficit hyperactivity disorder	0.00174	0.0333	CbGeAlD
Sumatriptan—HTR3A—forebrain—attention deficit hyperactivity disorder	0.00162	0.0311	CbGeAlD
Sumatriptan—HTR1F—brain—attention deficit hyperactivity disorder	0.00138	0.0265	CbGeAlD
Sumatriptan—HTR1B—forebrain—attention deficit hyperactivity disorder	0.00136	0.0261	CbGeAlD
Sumatriptan—HTR1D—forebrain—attention deficit hyperactivity disorder	0.00132	0.0253	CbGeAlD
Sumatriptan—SLCO1A2—forebrain—attention deficit hyperactivity disorder	0.00128	0.0246	CbGeAlD
Sumatriptan—Naratriptan—MAOA—attention deficit hyperactivity disorder	0.00116	0.151	CrCbGaD
Sumatriptan—HTR1B—cardiovascular system—attention deficit hyperactivity disorder	0.00115	0.0221	CbGeAlD
Sumatriptan—HTR1D—cardiovascular system—attention deficit hyperactivity disorder	0.00111	0.0214	CbGeAlD
Sumatriptan—Naratriptan—HTR1B—attention deficit hyperactivity disorder	0.0011	0.144	CrCbGaD
Sumatriptan—HTR1A—forebrain—attention deficit hyperactivity disorder	0.0011	0.0211	CbGeAlD
Sumatriptan—MAOA—forebrain—attention deficit hyperactivity disorder	0.001	0.0193	CbGeAlD
Sumatriptan—DRD2—forebrain—attention deficit hyperactivity disorder	0.000993	0.019	CbGeAlD
Sumatriptan—Rizatriptan—MAOA—attention deficit hyperactivity disorder	0.000957	0.125	CrCbGaD
Sumatriptan—HTR1A—cardiovascular system—attention deficit hyperactivity disorder	0.000929	0.0178	CbGeAlD
Sumatriptan—Rizatriptan—HTR1B—attention deficit hyperactivity disorder	0.000914	0.12	CrCbGaD
Sumatriptan—HTR1B—midbrain—attention deficit hyperactivity disorder	0.000899	0.0172	CbGeAlD
Sumatriptan—HTR3A—nervous system—attention deficit hyperactivity disorder	0.000881	0.0169	CbGeAlD
Sumatriptan—Zolmitriptan—MAOA—attention deficit hyperactivity disorder	0.000876	0.115	CrCbGaD
Sumatriptan—HTR1D—midbrain—attention deficit hyperactivity disorder	0.00087	0.0167	CbGeAlD
Sumatriptan—MAOA—cardiovascular system—attention deficit hyperactivity disorder	0.000849	0.0163	CbGeAlD
Sumatriptan—HTR3A—central nervous system—attention deficit hyperactivity disorder	0.000848	0.0163	CbGeAlD
Sumatriptan—SLCO1A2—midbrain—attention deficit hyperactivity disorder	0.000846	0.0162	CbGeAlD
Sumatriptan—Zolmitriptan—HTR1B—attention deficit hyperactivity disorder	0.000836	0.11	CrCbGaD
Sumatriptan—HTR1B—nervous system—attention deficit hyperactivity disorder	0.000739	0.0142	CbGeAlD
Sumatriptan—HTR1A—midbrain—attention deficit hyperactivity disorder	0.000725	0.0139	CbGeAlD
Sumatriptan—HTR1D—nervous system—attention deficit hyperactivity disorder	0.000715	0.0137	CbGeAlD
Sumatriptan—HTR1B—central nervous system—attention deficit hyperactivity disorder	0.000711	0.0137	CbGeAlD
Sumatriptan—SLCO1A2—nervous system—attention deficit hyperactivity disorder	0.000695	0.0133	CbGeAlD
Sumatriptan—HTR1D—central nervous system—attention deficit hyperactivity disorder	0.000689	0.0132	CbGeAlD
Sumatriptan—HTR3A—brain—attention deficit hyperactivity disorder	0.000673	0.0129	CbGeAlD
Sumatriptan—SLCO1A2—central nervous system—attention deficit hyperactivity disorder	0.000669	0.0128	CbGeAlD
Sumatriptan—Almotriptan—MAOA—attention deficit hyperactivity disorder	0.000664	0.0869	CrCbGaD
Sumatriptan—MAOA—midbrain—attention deficit hyperactivity disorder	0.000663	0.0127	CbGeAlD
Sumatriptan—DRD2—midbrain—attention deficit hyperactivity disorder	0.000655	0.0126	CbGeAlD
Sumatriptan—SLCO1A2—cerebellum—attention deficit hyperactivity disorder	0.000654	0.0126	CbGeAlD
Sumatriptan—Almotriptan—HTR1B—attention deficit hyperactivity disorder	0.000633	0.083	CrCbGaD
Sumatriptan—HTR1A—nervous system—attention deficit hyperactivity disorder	0.000596	0.0114	CbGeAlD
Sumatriptan—ABCG2—midbrain—attention deficit hyperactivity disorder	0.000574	0.011	CbGeAlD
Sumatriptan—HTR1A—central nervous system—attention deficit hyperactivity disorder	0.000574	0.011	CbGeAlD
Sumatriptan—HTR1B—brain—attention deficit hyperactivity disorder	0.000565	0.0108	CbGeAlD
Sumatriptan—HTR1A—cerebellum—attention deficit hyperactivity disorder	0.000561	0.0108	CbGeAlD
Sumatriptan—HTR1D—brain—attention deficit hyperactivity disorder	0.000547	0.0105	CbGeAlD
Sumatriptan—MAOA—nervous system—attention deficit hyperactivity disorder	0.000545	0.0105	CbGeAlD
Sumatriptan—DRD2—nervous system—attention deficit hyperactivity disorder	0.000539	0.0103	CbGeAlD
Sumatriptan—SLCO1A2—brain—attention deficit hyperactivity disorder	0.000531	0.0102	CbGeAlD
Sumatriptan—MAOA—central nervous system—attention deficit hyperactivity disorder	0.000524	0.0101	CbGeAlD
Sumatriptan—DRD2—central nervous system—attention deficit hyperactivity disorder	0.000519	0.00996	CbGeAlD
Sumatriptan—MAOA—cerebellum—attention deficit hyperactivity disorder	0.000513	0.00984	CbGeAlD
Sumatriptan—DRD2—cerebellum—attention deficit hyperactivity disorder	0.000507	0.00973	CbGeAlD
Sumatriptan—Eletriptan—HTR1B—attention deficit hyperactivity disorder	0.000493	0.0647	CrCbGaD
Sumatriptan—HTR1A—brain—attention deficit hyperactivity disorder	0.000456	0.00875	CbGeAlD
Sumatriptan—ABCG2—cerebellum—attention deficit hyperactivity disorder	0.000444	0.00853	CbGeAlD
Sumatriptan—ABCB1—forebrain—attention deficit hyperactivity disorder	0.000429	0.00823	CbGeAlD
Sumatriptan—MAOA—brain—attention deficit hyperactivity disorder	0.000416	0.00799	CbGeAlD
Sumatriptan—DRD2—brain—attention deficit hyperactivity disorder	0.000412	0.0079	CbGeAlD
Sumatriptan—ABCB1—cardiovascular system—attention deficit hyperactivity disorder	0.000363	0.00696	CbGeAlD
Sumatriptan—ABCG2—brain—attention deficit hyperactivity disorder	0.000361	0.00693	CbGeAlD
Sumatriptan—ABCB1—midbrain—attention deficit hyperactivity disorder	0.000283	0.00544	CbGeAlD
Sumatriptan—ABCB1—nervous system—attention deficit hyperactivity disorder	0.000233	0.00447	CbGeAlD
Sumatriptan—ABCB1—central nervous system—attention deficit hyperactivity disorder	0.000224	0.0043	CbGeAlD
Sumatriptan—ABCB1—cerebellum—attention deficit hyperactivity disorder	0.000219	0.00421	CbGeAlD
Sumatriptan—ABCB1—brain—attention deficit hyperactivity disorder	0.000178	0.00342	CbGeAlD
Sumatriptan—HTR1B—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	7.29e-05	0.000507	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.27e-05	0.000505	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR1B—attention deficit hyperactivity disorder	7.24e-05	0.000503	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	7.2e-05	0.000501	CbGpPWpGaD
Sumatriptan—HTR1B—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	7.2e-05	0.0005	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	7.2e-05	0.0005	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	7.18e-05	0.000499	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	7.13e-05	0.000495	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	7.12e-05	0.000495	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—GRM7—attention deficit hyperactivity disorder	7.1e-05	0.000494	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	6.98e-05	0.000485	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	6.91e-05	0.00048	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.85e-05	0.000476	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	6.75e-05	0.000469	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD1—attention deficit hyperactivity disorder	6.73e-05	0.000467	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	6.72e-05	0.000467	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—DRD2—attention deficit hyperactivity disorder	6.71e-05	0.000466	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	6.71e-05	0.000466	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	6.69e-05	0.000465	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	6.58e-05	0.000457	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	6.58e-05	0.000457	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD3—attention deficit hyperactivity disorder	6.52e-05	0.000453	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	6.5e-05	0.000452	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	6.46e-05	0.000449	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.41e-05	0.000445	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—ADRA2A—attention deficit hyperactivity disorder	6.4e-05	0.000445	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—DRD4—attention deficit hyperactivity disorder	6.33e-05	0.000439	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—HRH3—attention deficit hyperactivity disorder	6.3e-05	0.000438	CbGpPWpGaD
Sumatriptan—HTR1D—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.3e-05	0.000438	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	6.29e-05	0.000437	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	6.28e-05	0.000436	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	6.28e-05	0.000436	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	6.27e-05	0.000436	CbGpPWpGaD
Sumatriptan—HTR1B—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	6.17e-05	0.000429	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	6.08e-05	0.000422	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	6.05e-05	0.000421	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	6e-05	0.000417	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	5.98e-05	0.000415	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	5.98e-05	0.000415	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	5.9e-05	0.00041	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	5.85e-05	0.000407	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	5.83e-05	0.000405	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	5.65e-05	0.000393	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	5.55e-05	0.000386	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—HTR1B—attention deficit hyperactivity disorder	5.51e-05	0.000383	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	5.5e-05	0.000382	CbGpPWpGaD
Sumatriptan—HTR1A—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	5.49e-05	0.000381	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	5.49e-05	0.000381	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.44e-05	0.000378	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	5.43e-05	0.000377	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	5.33e-05	0.00037	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	5.32e-05	0.000369	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—ADRA2C—attention deficit hyperactivity disorder	5.25e-05	0.000365	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—DRD5—attention deficit hyperactivity disorder	5.14e-05	0.000357	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—DRD1—attention deficit hyperactivity disorder	5.12e-05	0.000356	CbGpPWpGaD
Sumatriptan—MAOA—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	5.11e-05	0.000355	CbGpPWpGaD
Sumatriptan—SLCO1A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	5.11e-05	0.000355	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—DRD2—attention deficit hyperactivity disorder	5.11e-05	0.000355	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	5e-05	0.000348	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—DRD3—attention deficit hyperactivity disorder	4.96e-05	0.000345	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.94e-05	0.000343	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	4.9e-05	0.00034	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—ADRA2A—attention deficit hyperactivity disorder	4.88e-05	0.000339	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.87e-05	0.000338	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	4.84e-05	0.000336	CbGpPWpGaD
Sumatriptan—DRD2—GPCRs, Class A Rhodopsin-like—HTR2A—attention deficit hyperactivity disorder	4.82e-05	0.000335	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—DRD4—attention deficit hyperactivity disorder	4.82e-05	0.000335	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.8e-05	0.000333	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.78e-05	0.000332	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—ADRA2C—attention deficit hyperactivity disorder	4.76e-05	0.000331	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	4.75e-05	0.00033	CbGpPWpGaD
Sumatriptan—ABCB1—HIF-1-alpha transcription factor network—EP300—attention deficit hyperactivity disorder	4.7e-05	0.000327	CbGpPWpGaD
Sumatriptan—HTR1A—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.7e-05	0.000327	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	4.7e-05	0.000326	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—DRD5—attention deficit hyperactivity disorder	4.67e-05	0.000324	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	4.56e-05	0.000317	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.51e-05	0.000313	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—attention deficit hyperactivity disorder	4.49e-05	0.000312	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.42e-05	0.000307	CbGpPWpGaD
Sumatriptan—SLCO1B1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.37e-05	0.000304	CbGpPWpGaD
Sumatriptan—HTR1A—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	4.35e-05	0.000302	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	4.33e-05	0.000301	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	4.32e-05	0.0003	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.3e-05	0.000299	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.28e-05	0.000297	CbGpPWpGaD
Sumatriptan—HTR1F—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	4.24e-05	0.000295	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.21e-05	0.000293	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.21e-05	0.000292	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	4.21e-05	0.000292	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—GRM7—attention deficit hyperactivity disorder	4.2e-05	0.000292	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	4.19e-05	0.000291	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.16e-05	0.000289	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.16e-05	0.000289	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.13e-05	0.000287	CbGpPWpGaD
Sumatriptan—DRD2—Class A/1 (Rhodopsin-like receptors)—HTR2A—attention deficit hyperactivity disorder	4.13e-05	0.000287	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	4.12e-05	0.000286	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	4.12e-05	0.000286	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	4.07e-05	0.000283	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	4.06e-05	0.000282	CbGpPWpGaD
Sumatriptan—ABCG2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	4.05e-05	0.000281	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	4.04e-05	0.000281	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	4.01e-05	0.000279	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	3.99e-05	0.000277	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	3.93e-05	0.000273	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.89e-05	0.00027	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.87e-05	0.000269	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ADRA2C—attention deficit hyperactivity disorder	3.85e-05	0.000268	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	3.85e-05	0.000268	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.82e-05	0.000266	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	3.81e-05	0.000265	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	3.79e-05	0.000263	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.77e-05	0.000262	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	3.74e-05	0.00026	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.73e-05	0.000259	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	3.71e-05	0.000258	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	3.7e-05	0.000257	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.68e-05	0.000256	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	3.59e-05	0.00025	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.58e-05	0.000249	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—HRH3—attention deficit hyperactivity disorder	3.56e-05	0.000248	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.55e-05	0.000246	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	3.53e-05	0.000245	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.52e-05	0.000244	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	3.49e-05	0.000242	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	3.44e-05	0.000239	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—TPH2—attention deficit hyperactivity disorder	3.36e-05	0.000233	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.36e-05	0.000233	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—DPYD—attention deficit hyperactivity disorder	3.3e-05	0.00023	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	3.3e-05	0.000229	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—STUB1—attention deficit hyperactivity disorder	3.28e-05	0.000228	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	3.25e-05	0.000226	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HRH3—attention deficit hyperactivity disorder	3.24e-05	0.000225	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	3.22e-05	0.000224	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	3.21e-05	0.000223	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	3.19e-05	0.000222	CbGpPWpGaD
Sumatriptan—DRD2—GPCR ligand binding—HTR2A—attention deficit hyperactivity disorder	3.14e-05	0.000218	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	3.14e-05	0.000218	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	3.14e-05	0.000218	CbGpPWpGaD
Sumatriptan—DRD2—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	3.12e-05	0.000217	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—HTR1B—attention deficit hyperactivity disorder	3.11e-05	0.000216	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—TPH2—attention deficit hyperactivity disorder	3.11e-05	0.000216	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CACNB2—attention deficit hyperactivity disorder	3.11e-05	0.000216	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	3.1e-05	0.000215	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	3.08e-05	0.000214	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	3.07e-05	0.000213	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—DPYD—attention deficit hyperactivity disorder	3.06e-05	0.000213	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.99e-05	0.000208	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.92e-05	0.000203	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.9e-05	0.000201	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—DRD1—attention deficit hyperactivity disorder	2.9e-05	0.000201	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—DRD2—attention deficit hyperactivity disorder	2.89e-05	0.000201	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.87e-05	0.0002	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—TPH2—attention deficit hyperactivity disorder	2.87e-05	0.0002	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.86e-05	0.000199	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.85e-05	0.000198	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.85e-05	0.000198	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HTR1B—attention deficit hyperactivity disorder	2.83e-05	0.000196	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—DPYD—attention deficit hyperactivity disorder	2.83e-05	0.000196	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.82e-05	0.000196	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADRA2C—attention deficit hyperactivity disorder	2.81e-05	0.000196	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—DRD3—attention deficit hyperactivity disorder	2.8e-05	0.000195	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DRD5—attention deficit hyperactivity disorder	2.76e-05	0.000192	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—ADRA2A—attention deficit hyperactivity disorder	2.76e-05	0.000191	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—DRD4—attention deficit hyperactivity disorder	2.72e-05	0.000189	CbGpPWpGaD
Sumatriptan—HTR1D—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.71e-05	0.000188	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—RTN4—attention deficit hyperactivity disorder	2.7e-05	0.000188	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.69e-05	0.000187	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—TPH2—attention deficit hyperactivity disorder	2.66e-05	0.000185	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.66e-05	0.000185	CbGpPWpGaD
Sumatriptan—HTR1B—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.66e-05	0.000184	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—DRD1—attention deficit hyperactivity disorder	2.63e-05	0.000183	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.63e-05	0.000183	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—DRD2—attention deficit hyperactivity disorder	2.62e-05	0.000182	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—DPYD—attention deficit hyperactivity disorder	2.62e-05	0.000182	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.56e-05	0.000178	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	2.55e-05	0.000177	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—DRD3—attention deficit hyperactivity disorder	2.55e-05	0.000177	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—ADRA2A—attention deficit hyperactivity disorder	2.5e-05	0.000174	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.49e-05	0.000173	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—DRD4—attention deficit hyperactivity disorder	2.47e-05	0.000172	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.46e-05	0.000171	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.43e-05	0.000169	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	2.41e-05	0.000168	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.37e-05	0.000165	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.37e-05	0.000165	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	2.32e-05	0.000161	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.3e-05	0.00016	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.3e-05	0.00016	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	2.27e-05	0.000158	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.26e-05	0.000157	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	2.25e-05	0.000156	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.23e-05	0.000155	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	2.21e-05	0.000154	CbGpPWpGaD
Sumatriptan—ABCB1—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	2.19e-05	0.000152	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.19e-05	0.000152	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	2.18e-05	0.000152	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	2.18e-05	0.000151	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.13e-05	0.000148	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ADRA2C—attention deficit hyperactivity disorder	2.08e-05	0.000145	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.08e-05	0.000144	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—COMT—attention deficit hyperactivity disorder	2.04e-05	0.000141	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	2.03e-05	0.000141	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.02e-05	0.000141	CbGpPWpGaD
Sumatriptan—HTR1A—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	2.02e-05	0.000141	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—MAOA—attention deficit hyperactivity disorder	2.02e-05	0.00014	CbGpPWpGaD
Sumatriptan—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—attention deficit hyperactivity disorder	2.01e-05	0.00014	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.96e-05	0.000136	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HRH3—attention deficit hyperactivity disorder	1.91e-05	0.000133	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.9e-05	0.000132	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—COMT—attention deficit hyperactivity disorder	1.89e-05	0.000131	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.84e-05	0.000128	CbGpPWpGaD
Sumatriptan—DRD2—GPCR downstream signaling—HTR2A—attention deficit hyperactivity disorder	1.78e-05	0.000123	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.77e-05	0.000123	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—COMT—attention deficit hyperactivity disorder	1.74e-05	0.000121	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—MAOA—attention deficit hyperactivity disorder	1.73e-05	0.00012	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.71e-05	0.000119	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.68e-05	0.000117	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism of lipids and lipoproteins—EP300—attention deficit hyperactivity disorder	1.68e-05	0.000116	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR1B—attention deficit hyperactivity disorder	1.67e-05	0.000116	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.66e-05	0.000116	CbGpPWpGaD
Sumatriptan—DRD2—Signaling by GPCR—HTR2A—attention deficit hyperactivity disorder	1.61e-05	0.000112	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—COMT—attention deficit hyperactivity disorder	1.61e-05	0.000112	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—MAOA—attention deficit hyperactivity disorder	1.6e-05	0.000111	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DRD1—attention deficit hyperactivity disorder	1.55e-05	0.000108	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—DRD2—attention deficit hyperactivity disorder	1.55e-05	0.000108	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DRD3—attention deficit hyperactivity disorder	1.5e-05	0.000105	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—ADRA2A—attention deficit hyperactivity disorder	1.48e-05	0.000103	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—DRD4—attention deficit hyperactivity disorder	1.46e-05	0.000101	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.45e-05	0.000101	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—TPH2—attention deficit hyperactivity disorder	1.44e-05	9.99e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CACNB2—attention deficit hyperactivity disorder	1.44e-05	9.99e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.42e-05	9.9e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—DPYD—attention deficit hyperactivity disorder	1.41e-05	9.83e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—CACNA1C—attention deficit hyperactivity disorder	1.32e-05	9.14e-05	CbGpPWpGaD
Sumatriptan—HTR1F—Signaling Pathways—EP300—attention deficit hyperactivity disorder	1.21e-05	8.37e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—SNAP25—attention deficit hyperactivity disorder	1.15e-05	7.99e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—ADRA2A—attention deficit hyperactivity disorder	1.09e-05	7.6e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	1.09e-05	7.54e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—HTR2A—attention deficit hyperactivity disorder	9.53e-06	6.62e-05	CbGpPWpGaD
Sumatriptan—SLCO1A2—Metabolism—EP300—attention deficit hyperactivity disorder	8.73e-06	6.06e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—COMT—attention deficit hyperactivity disorder	8.71e-06	6.05e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—MAOA—attention deficit hyperactivity disorder	8.65e-06	6.01e-05	CbGpPWpGaD
Sumatriptan—MAOA—Metabolism—EP300—attention deficit hyperactivity disorder	8.09e-06	5.62e-05	CbGpPWpGaD
Sumatriptan—HTR1D—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.71e-06	5.35e-05	CbGpPWpGaD
Sumatriptan—HTR1B—Signaling Pathways—EP300—attention deficit hyperactivity disorder	7.55e-06	5.24e-05	CbGpPWpGaD
Sumatriptan—SLCO1B1—Metabolism—EP300—attention deficit hyperactivity disorder	7.46e-06	5.19e-05	CbGpPWpGaD
Sumatriptan—ABCG2—Metabolism—EP300—attention deficit hyperactivity disorder	6.91e-06	4.8e-05	CbGpPWpGaD
Sumatriptan—HTR1A—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.75e-06	3.99e-05	CbGpPWpGaD
Sumatriptan—DRD2—Signaling Pathways—EP300—attention deficit hyperactivity disorder	5.05e-06	3.51e-05	CbGpPWpGaD
Sumatriptan—ABCB1—Metabolism—EP300—attention deficit hyperactivity disorder	3.74e-06	2.6e-05	CbGpPWpGaD
